{
    "nctId": "NCT04136782",
    "briefTitle": "Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer",
    "officialTitle": "Albumin-bound Paclitaxel Combined With Carboplatin Versus Epirubicin Combined With Docetaxel as Neoadjuvant Therapy for Triple-negative Breast Cancer: a Multicenter Randomized Controlled Phase IV Clinical Trial",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 110,
    "primaryOutcomeMeasure": "Pathologic complete remission rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* patients developing breast cancer as confirmed by X-ray examination, cancer tissue negative for estrogen receptor, progesterone receptor and HER2, and tumor stage II-III;\n* estimated survival \\> 3 months;\n* presence of clinically measurable lesions;\n* Karnofsky functional status score \u2265 70;\n* normal routine blood test results, normal liver and kidney function, and near normal electrocardiographic manifestations;\n* age at 18-70 years.\n\nExclusion Criteria:\n\n* stage IV breast cancer patients with bone metastasis or other distant metastasis;\n* severe renal insufficiency;\n* older adult patients with severe organic diseases such as heart and lung diseases, who are not estimated to be able to tolerate chemotherapy;\n* those who have received antineoplastic therapy;\n* those who have received neoadjuvant chemotherapy but fail in 2 cycles of neoadjuvant chemotherapy and switch to other regimens or terminate chemotherapy;\n* those with history of other malignant tumors;\n* those with severe heart, liver, and kidney organ dysfunction or poor health who cannot tolerate chemotherapy, or those who cannot tolerate chemotherapy and switch to other therapeutic regimens;\n* those with mental and nervous system diseases who cannot comply with treatment;\n* those with dexamethasone intolerance or those who are highly allergic to any drug in neoadjuvant chemotherapy;\n* pregnant or lactating women;\n* those who are participating in other trials.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}